- Home
- ASPC vs TELA Comparison
ASPC vs TELA Comparison
Compare ASPC & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPC
- TELA
- Stock Information
- Founded
- ASPC 2024
- TELA 2012
- Country
- ASPC Hong Kong
- TELA United States
- Employees
- ASPC N/A
- TELA N/A
- Industry
- ASPC
- TELA Medical/Dental Instruments
- Sector
- ASPC
- TELA Health Care
- Exchange
- ASPC Nasdaq
- TELA Nasdaq
- Market Cap
- ASPC 82.6M
- TELA 80.7M
- IPO Year
- ASPC 2024
- TELA 2019
- Fundamental
- Price
- ASPC $10.27
- TELA $2.13
- Analyst Decision
- ASPC
- TELA Strong Buy
- Analyst Count
- ASPC 0
- TELA 4
- Target Price
- ASPC N/A
- TELA $6.00
- AVG Volume (30 Days)
- ASPC 3.2K
- TELA 60.2K
- Earning Date
- ASPC 01-01-0001
- TELA 08-11-2025
- Dividend Yield
- ASPC N/A
- TELA N/A
- EPS Growth
- ASPC N/A
- TELA N/A
- EPS
- ASPC 0.05
- TELA N/A
- Revenue
- ASPC N/A
- TELA $71,217,000.00
- Revenue This Year
- ASPC N/A
- TELA $26.67
- Revenue Next Year
- ASPC N/A
- TELA $22.63
- P/E Ratio
- ASPC $220.96
- TELA N/A
- Revenue Growth
- ASPC N/A
- TELA 12.78
- 52 Week Low
- ASPC $9.95
- TELA $0.86
- 52 Week High
- ASPC $10.51
- TELA $4.78
- Technical
- Relative Strength Index (RSI)
- ASPC N/A
- TELA 61.31
- Support Level
- ASPC N/A
- TELA $1.95
- Resistance Level
- ASPC N/A
- TELA $2.16
- Average True Range (ATR)
- ASPC 0.00
- TELA 0.16
- MACD
- ASPC 0.00
- TELA -0.01
- Stochastic Oscillator
- ASPC 0.00
- TELA 63.17
About ASPC A SPAC III Acquisition Corp. Class A Ordinary Shares
A SPAC III Acquisition Corp is a blank check company.
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.